Millendo Therapeutics
Why Robinhood?
You can watch MLND and buy or sell other stocks, ETFs, and their options commission-free!About MLND
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
MLND Key Statistics
Stock Snapshot
As of today, Millendo Therapeutics(MLND) shares are valued at $4.13. The company's market cap stands at 20.35M, with a P/E ratio of -0.31.
On 2026-05-15, Millendo Therapeutics(MLND) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Millendo Therapeutics(MLND) stock has reached 0, versus its average volume of 130.72K.
The stock's 52-week range extends from a low of $1.50 to a high of $12.23.
The stock's 52-week range extends from a low of $1.50 to a high of $12.23.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.